ZNF22 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	18 studies	27% ± 12%	Explore
natural killer cell	15 studies	20% ± 5%	Explore
fibroblast	15 studies	27% ± 8%	Explore
pericyte	12 studies	26% ± 10%	Explore
CD8-positive, alpha-beta T cell	12 studies	21% ± 9%	Explore
plasmacytoid dendritic cell	12 studies	28% ± 6%	Explore
naive B cell	11 studies	19% ± 3%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	21% ± 9%	Explore
B cell	11 studies	25% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	20% ± 4%	Explore
CD16-positive, CD56-dim natural killer cell, human	9 studies	21% ± 4%	Explore
capillary endothelial cell	9 studies	25% ± 11%	Explore
endothelial cell of artery	9 studies	27% ± 14%	Explore
smooth muscle cell	9 studies	26% ± 7%	Explore
connective tissue cell	8 studies	32% ± 11%	Explore
mucosal invariant T cell	8 studies	18% ± 3%	Explore
endothelial cell of lymphatic vessel	7 studies	24% ± 7%	Explore
myofibroblast cell	7 studies	26% ± 5%	Explore
gamma-delta T cell	7 studies	27% ± 20%	Explore
epithelial cell	6 studies	34% ± 17%	Explore
precursor B cell	6 studies	35% ± 13%	Explore
endothelial cell of vascular tree	6 studies	19% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	18% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	23% ± 5%	Explore
progenitor cell	5 studies	24% ± 8%	Explore
vein endothelial cell	5 studies	26% ± 9%	Explore
hematopoietic stem cell	5 studies	35% ± 11%	Explore
pro-B cell	5 studies	45% ± 8%	Explore
memory B cell	5 studies	18% ± 2%	Explore
hematopoietic precursor cell	4 studies	46% ± 19%	Explore
CD4-positive, alpha-beta T cell	4 studies	28% ± 9%	Explore
mature NK T cell	4 studies	17% ± 2%	Explore
mesothelial cell	4 studies	34% ± 13%	Explore
basal cell	4 studies	26% ± 10%	Explore
immature B cell	4 studies	23% ± 5%	Explore
oligodendrocyte precursor cell	4 studies	24% ± 8%	Explore
pancreatic A cell	3 studies	28% ± 1%	Explore
type B pancreatic cell	3 studies	30% ± 7%	Explore
conventional dendritic cell	3 studies	25% ± 10%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	22% ± 4%	Explore
T cell	3 studies	30% ± 12%	Explore
neural crest cell	3 studies	39% ± 5%	Explore
lymphocyte	3 studies	20% ± 4%	Explore
ciliated cell	3 studies	26% ± 5%	Explore
abnormal cell	3 studies	18% ± 2%	Explore
exhausted T cell	3 studies	17% ± 1%	Explore
neuron	3 studies	32% ± 17%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	39% ± 29%	Explore
enteroendocrine cell	3 studies	31% ± 13%	Explore
goblet cell	3 studies	28% ± 10%	Explore
intestinal crypt stem cell	3 studies	20% ± 3%	Explore
glial cell	3 studies	33% ± 22%	Explore
double negative thymocyte	3 studies	37% ± 23%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	5 studies	22% ± 10%	Explore
intestine	5 studies	26% ± 13%	Explore
lung	5 studies	26% ± 9%	Explore
pancreas	3 studies	28% ± 4%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
ovary	100%	1179.49	180 / 180	100%	37.81	430 / 430
pancreas	100%	1258.71	328 / 328	100%	29.15	178 / 178
brain	100%	835.07	2640 / 2642	100%	58.45	704 / 705
uterus	100%	1273.37	170 / 170	100%	37.31	457 / 459
prostate	100%	1127.84	245 / 245	99%	51.12	499 / 502
thymus	100%	1311.20	653 / 653	99%	41.18	601 / 605
lung	100%	1214.12	577 / 578	99%	29.67	1145 / 1155
liver	100%	1078.59	226 / 226	99%	27.33	401 / 406
kidney	100%	980.60	89 / 89	99%	33.89	889 / 901
bladder	100%	954.86	21 / 21	98%	29.04	495 / 504
breast	100%	1659.73	459 / 459	98%	37.80	1092 / 1118
esophagus	99%	772.78	1436 / 1445	97%	21.57	177 / 183
intestine	100%	1064.12	966 / 966	95%	26.78	501 / 527
stomach	100%	822.09	359 / 359	94%	22.32	270 / 286
adrenal gland	100%	584.85	258 / 258	86%	18.13	198 / 230
skin	98%	755.14	1774 / 1809	88%	24.93	415 / 472
adipose	100%	1711.29	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	42.21	29 / 29
spleen	100%	1373.78	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	27.94	45 / 45
blood vessel	100%	800.96	1331 / 1335	0%	0	0 / 0
heart	100%	665.16	858 / 861	0%	0	0 / 0
muscle	96%	421.48	769 / 803	0%	0	0 / 0
eye	0%	0	0 / 0	95%	21.55	76 / 80
peripheral blood	63%	517.30	583 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0042476	Biological process	odontogenesis
GO_0006355	Biological process	regulation of DNA-templated transcription
GO_0005654	Cellular component	nucleoplasm
GO_0005634	Cellular component	nucleus
GO_0003677	Molecular function	DNA binding
GO_0003700	Molecular function	DNA-binding transcription factor activity
GO_0005515	Molecular function	protein binding
GO_0008270	Molecular function	zinc ion binding

IV. Literature review

[source]

Gene name	ZNF22
Protein name	Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26)
Synonyms	KOX15 KROX26
Description	FUNCTION: Binds DNA through the consensus sequence 5'-CAATG-3'. May be involved in transcriptional regulation and may play a role in tooth formation (By similarity). .
Accessions	ENST00000298299.4 P17026

ZNF22 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review